Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Singapore eDevelopment Limited
Singapore eDevelopment Limited
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Overcoming CMC challenges in cell and gene therapy: part I
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
Resolving capping issues in tablet manufacturing
Natoli explores the various causes of capping and the methods to prevent it
Effective ways to optimise heat exchangers
Heat exchangers are used within a wide range of process industries as a way to transfer heat between two fluid streams across a medium in an energy conservative way
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Ingredients
Impact Biomedical initiates research programme to solve the patent cliff
The primary cause of the patent crisis is that most techniques for modifying natural molecules to pharmaceutical grade products are essentially 'played out'
Research & Development
Equivir shows prophylactic COVID-19 results in independent testing
Impact Biomedical has announced in vitro success with Equivir and 3F Biofragrance against COVID-19 in independent laboratory testing
Ingredients
Impact BioMedical looks at compounds that block coronavirus mechanisms
The coronavirus has presented a unique challenge to exploit a 'hand shake' docking site to human cellular membranes that is atypical of Influenza and Rhinovirus
Research & Development
Singapore eDevelopment researches universal drug platform
Six month target for validating lab data, twelve month target for completion of platform
Subscribe now